1 Boumpas DT , Austin III HA , Vaughn EM et al. Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophos-phamide in severe lupus nephritis . Lancet1992; 340: 741-745 .
2.
2 Gourley MF , Austin HA, 3rd , Scott D et al. Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial . Ann Intern Med1996; 125: 549-557 .
4 Petri M . Musculoskeletal complications of systemic lupus erythematosus in the Hopkins Lupus Cohort: an update . Arthritis Care Res1995; 8: 137-145 .
5.
5 Zonana-Nacach A , Barr SG , Magder LS , Petri M . Damage in systemic lupus erythematosus and its association with corticosteroids. Arthritis Rheum (in press).
6.
6 Boumpas DT , Austin III HA , Vaughan EM , Yarboro CH , Klippel JH , Balow JE . Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy . Ann Intern Med1993; 119: 366-369 .
7.
7 Langevitz P , Klein L , Pras M , Many A . The effect of cyclophos-phamide pulses on fertility in patients with lupus nephritis . Am J Reprod Immunol1992; 28: 157-158 .
8.
8 Mok CC , Lau CS , Wong RWS . Risk factors for ovarian failure in patients with systemic lupus erythematosus receiving cyclophospha-mide therapy . Arthritis Rheum1998; 41: 831-837 .
9.
9 Wang CL , Wang F , Bosco JJ . Ovarian failure in oral cyclophos-phamide treatment for systemic lupus erythematosus . Lupus1995; 4: 11-14 .
10.
10 Ben-Chetrit A , Ben-Chetrit E . Systemic lupus erythematosus induced by ovulation induction treatment . Arthritis Rheum1994; 37: 1614-1617 .
11.
11 Guballa N , Sammaritano L , Schwartzman S , Buyon J , Lockshin MD . Ovulation induction and in vitro fertilization in systemic lupus erythematosus and antiphospholipid syndrome . Arthritis Rheum2000; 43: 550-556 .
12.
12 Mok CC , Wong RW , Lau CS . Ovarian failure and flares of systemic lupus erythematosus . Arthritis Rheum1999; 42: 1274-1280 .
13.
13 Petri M . Hopkins Lupus Pregnancy Center: 1987 to 1996 . Rheumatic Dis Clinics N Am1997; 23: 1-14 .
14.
14 Weisman MH , Bluestein HG , Berner CM , de Haan HA . Reduction in circulating dsDNA antibody titer after administration of LIP 394 . J Rheumatol1997; 24: 314-318 .
15.
15 Chapman RM , Sutcliffe SB . Protection of ovarian function by oral contraceptives in women receiving chemotherapy for Hogkin's disease . Blood1981; 58: 849-851 .
16.
16 Blumenfeld Z , Avivi I , Linn S , Epelbaum R , Ben-Shahar M , Haim N . Prevention of irreversible chemotherapy-induced ovarian damage in young women with lymphoma by a gonadotropin-releasing hormone agonist in parallel to chemotherapy . Human Reprod1996; 11: 1620-1626 .
17.
17 Blumenfeld Z , Shapiro D , Shteinberg M , Avivi I , Nahir M . Preservation of fertility and ovarian function and minimizing gonadotoxicity in young women with systemic lupus erythematosus treated by chemotherapy . Lupus2000; 9: 401-405 .
18.
18 Julkunen HA . Oral contraceptives in systemic lupus erythematosus: side-effects and influence on the activity of SLE . Scand J Rheumatol1991; 20: 427-433 .
19.
19 Sanchez-Guerrero J , Karlson EW , Liang MH , Hunter DJ , Speizer FE , Colditz GA . Past use of oral contraceptives and the risk of developing systemic lupus erythematosus . Arthritis Rheum1997; 40: 804-808 .
20.
20 Petri M , Robinson C . Oral contraceptives and systemic lupus erythematosus . Arthritis Rheum1997; 40: 797-803 .
21.
21 Martin-Suarez I , D'Cnrz D , Mansoor M , Fernandes AP , Khamashta MA , Hughes GR . Immunosuppressive treatment in severe connective tissue diseases: effects of low dose intravenous cyclophosphamide . Ann Rheum Dis1997; 56: 481-487 .
22.
22 Brodsky RA , Petri M , Smith BD et al. Immunoblative high-dose cyclophosphamide without stem cell rescue for refractory, severe autoimmune disease . Ann Int Med1998; 129: 1031-1035 .
23.
23 Brodsky RA , Sensenbrenner LL , Jones RJ . Complete remission in severe aplastic anemia after high-dose cyclophosphamide without bone marrow transplantation . Blood1996; 87: 491-494 .
